Investigation Report on China's Propofol Market 2021-2025 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Propofol Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

According to the market research, the sales of Propofol in the Chinese market increased year by year from 2016 to 2019. Due to the impact of the new crown epidemic on the overall medical diagnosis and treatment services, the sales decreased from CNY1.232 billion in 2019 to CNY1.308 billion in 2020, with a year-on-year decrease of 14.28%. The CAGR of sales of Propofol in China from 2016 to 2020 is 1.89%.

Propofol is a short-acting intravenous anesthetic. Its uses include the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. It is also used for status epilepticus if other medications have not worked. Its product was developed by Fresenius Kabi Deutschland GmbH.

Propofol was approved for clinical use in China in 1994 and is currently included in China's medical insurance. As of the first half of 2021, there are 7 manufacturers in the Chinese Propofol market, among which Fresenius Kabi Deutschland GmbH accounts for the largest market share.

The analyst expects that the sales of Propofol will have a restorative growth from 2021 to 2025 with the effective alleviation of the new crown epidemic. In addition, Propofol has a fast onset, stable induction, and rapid and complete recovery. Based on these advantages, the sales volume of Propofol will increase steadily in the future.

Moreover, Propofol is also used in veterinary clinical anesthesia. With the expansion of China's pet market and servitization and standardization of pet hygiene, Propofol will also expand in the pet medicine market, driving the growth of its sales and sales volume.

Topics Covered:

• The impact of COVID-19 on China's Propofol market
• Sales value of China's Propofol 2016-2020
• Competitive landscape of China's Propofol market
• Prices of Propofol in China
• Prices of Propofol in China by regions and manufacturers
• Analysis of factors affecting the development of China's Propofol market
• Prospect of China's Propofol market from 2021 to 2025

Key Topics Covered:

1 Relevant Concept of Propofol

1.1 Indications for Propofol

1.2 Development of Propofol in China

1.3 Governmental Approval of Propofol in China

1.4 The Impact of COVID-19 on Propofol sales in China

2 Sales of Propofol in China, 2016-2020

2.1 Sales Value of Propofol

2.1.1 Overall Sales Value

2.1.2 Sales Value by Region

2.2 Sales Volume of Propofol

2.2.1 Overall Sales Volume

2.2.2 Sales Volume by Region

2.3 Sales of Propofol by Dosage Form in China, 2016-2020

2.3.1 Injection

2.3.2 Analysis of Other Dosage Form

3 Analysis of Major Propofol Manufacturers in China in 2020

3.1 Analysis of Market Share of Major Propofol Manufacturers

3.1.1 Investigation on Market Share by Sales Value

3.1.2 Investigation on Market Share by Sales volume

3.2 Fresenius Kabi Deutschland GmbH

3.2.1 Enterprise Profile

3.2.2 Sales of PROPOFOL 1% FRESENIUS AND PROPOFOL 2% FRESENIUS (Fresenius Kabi Deutschland GmbH's Propofol) in China

3.3 Aspen Pharma Trading Ltd

3.3.1 Enterprise Profile

3.3.2 Sales of DIPRIVAN (Aspen Pharma Trading Ltd's Propofol) in China

3.4 Sichuan Guorei Pharmaceutical Co., Ltd.

3.4.1 Enterprise Profile

3.4.2 Sales of Leweijing (Sichuan Guorei Pharmaceutical Co.,Ltd.'s Propofol) in China

3.5 Guangdong Jiabo Pharmaceutical Co., Ltd.

3.5.1 Enterprise Profile

3.5.2 Sales of Dishining (Guangdong Jiabo Pharmaceutical Co., Ltd.'s Propofol) in China

3.6 Xian Libang Pharmaceutical Co., Ltd.

3.6.1 Enterprise Profile

3.6.2 Sales of Limengxin (Xian Libang Pharmaceutical Co., Ltd.'s Propofol) in China

4 Prices of Propofol for Different Manufacturers in China, 2020-2021

4.1 Fresenius Kabi Deutschland GmbH (PROPOFOL 1% FRESENIUS AND PROPOFOL 2% FRESENIUS)

4.2 Aspen Pharma Trading Ltd (DIPRIVAN)

4.3 Sichuan Guorei Pharmaceutical Co., Ltd. (Leweijing)

4.4 Guangdong Jiabo Pharmaceutical Co., Ltd. (Dishining)

4.5 Xian Libang Pharmaceutical Co., Ltd. (Limengxin)

5 Prospect of Chinese Propofol Market, 2021-2025

5.1 Influential Factors of Chinese Propofol Market Development

5.1.1 The Impact of COVID-19 on Chinese Propofol Market

5.1.2 Market Drivers and Opportunities

5.1.3 Market Threats and Challenges

5.2 Forecast on Market Size

5.3 Forecast on Market Trend

For more information about this report visit https://www.researchandmarkets.com/r/o9npqf

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900